Form D · Biotechnology
PLUROGEN THERAPEUTICS INC
Norristown, PA · CIK 0001357019
Offering snapshot reported Apr 7, 2014 · SEC filing
- Reported sold
- $153K Offering amount: $3.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Apr 4, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2014 | Initial | $153,194 | No comparison | 3 | SEC filing |
| Jan 13, 2014 | Initial | $300,000 | No comparison | 4 | SEC filing |
| Oct 24, 2013 | Initial | $75,000 | No comparison | 2 | SEC filing |
| Nov 14, 2011 | Initial | $1,225,000 | No comparison | 2 | SEC filing |
| Oct 19, 2010 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Aug 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 2, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-215029
An initial closing will occur when issuer has raised $750,000 if raised by April 18, 2014, or such later date as determined by issuer's board of directors. The minimum investment of $5,000 may be waived at the discretion of issuer's board of directors.
Source: Form D, filed Apr 7, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Brody | Director |
| James B. Farinholt | Director |
| James B. Farinholt, Jr. | Director |
| Adam J. Katz | Director, Executive |
| Neal G Koller | Director, Executive |
| George T. Rodeheaver | Director, Executive |
| Wendy L. Yarno | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2495 General Armistead Avenue
Norristown, PA, 19403
Norristown, PA, 19403